Oncoinvent appoints Adrian Senderowicz MD to its Board of Directors
Company adds experienced clinical development expert to its board of directorsOSLO, Norway--(BUSINESS WIRE)--Oncoinvent AS announces that Adrian Senderowicz was elected as a Non-executive Director today at the Company's Extraordinary General Meeting.Adrian Senderowicz is a US Board certified medical oncologist, and...
Jana Alfheim Royh Larsen Adrian Senderowicz Jonas Einarson Oncology Drug Development Us National Cancer Institute
Source: pharmiweb.com